相关实验视频

Updated: Jul 4, 2025

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

一种算法来评估在社区获得的肺炎中选择抗生素的指南一致性

Julia K W Yarahuan^1,2, Susannah Kisvarday¹, Eugene Kim³

¹Department of Pediatrics, Divisions of aGeneral Pediatrics.

Hospital pediatrics

|January 30, 2024

概括

一个自动化算法准确地评估了社区获得性肺炎 (CAP) 的抗生素使用与使用电子健康记录的指导方针. 这减少了用于质量改进工作的手动图表审查.

科学领域:

医疗信息学医疗信息学
改善临床质量改善临床质量
抗生素管理局抗生素管理局

背景情况:

手动图表审查对于质量改进计划来说是耗时的.
评估社区获得性肺炎 (CAP) 抗生素选择是否符合指导方针需要大量的手工努力.
电子健康记录 (EHR) 数据为自动化质量评估提供了潜力.

研究的目的:

开发和验证一种算法,用于自动评估抗生素选择是否符合CAP指南.
为了减轻质量改善工作中手动图表审查的负担.
利用EHR数据进行高效准确的抗生素管理.

主要方法:

使用结构化和非结构化EHR数据开发了一个三部分算法.
该算法评估了遵守机构CAP临床实践指南的情况.
在儿童医院对2017-2019年的回顾性数据进行了绩效评估,医生审查员提供了基本真相.

主要成果:

该算法在452名验证患者的标签抗生素一致性方面实现了96%的整体准确性.
它在68%符合条件的患者中正确确定了符合指导方针的抗生素使用.
报告了高性能指标:灵敏度为0.96,积极预测值为0.97,F1得分为0.96.

结论:

使用EHR数据的自动化算法可以根据临床指南准确评估CAP的抗生素选择.
这种工具可以显著提高质量测量和改进工作的效率.
自动化EHR数据分析为抗生素管理计划提供了可扩展的解决方案.

更多相关视频

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung

Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung

Published on: January 22, 2021

相关概念视频

Pneumonia III: Complications and Assessment

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:

Pneumonia IV: Management

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:

Antibiotic Selection

Antibiotic Selection